These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 37182050)

  • 1. The Efficacy and Safety of Dr. SKS Hair Booster Serum (a Cocktail of Micronutrients and Multivitamins) in Adult Males and Females With Androgenetic Alopecia: An Open-Label, Non-randomized, Prospective Study.
    Khare S
    Cureus; 2023 Apr; 15(4):e37424. PubMed ID: 37182050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Dr. SKS Hair Booster Serum in the Treatment of Female Pattern Alopecia in Patients With PCOS: An Open-Label, Non-randomized, Prospective Study.
    Khare S
    Cureus; 2023 Sep; 15(9):e44941. PubMed ID: 37818523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between topical cetirizine with minoxidil versus topical placebo with minoxidil in female androgenetic alopecia: a randomized, double-blind, placebo-controlled study.
    Bassiouny EA; El-Samanoudy SI; Abbassi MM; Nada HR; Farid SF
    Arch Dermatol Res; 2023 Jul; 315(5):1293-1304. PubMed ID: 36571611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
    Marotta JC; Patel G; Carvalho M; Blakeney S
    Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
    Rossi A; Caro G
    J Cosmet Dermatol; 2024 Feb; 23(2):502-509. PubMed ID: 37798906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's New in Therapy for Male Androgenetic Alopecia?
    Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
    Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo
    Shome D; Kapoor R; Vadera S; Doshi K; Patel G; Mohammad Khan T
    J Cosmet Dermatol; 2021 Oct; 20(10):3299-3307. PubMed ID: 33826786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial.
    Balasundaram M; Kumari R; Ramassamy S
    J Dermatolog Treat; 2023 Dec; 34(1):2182618. PubMed ID: 36800229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo
    Clinic A; Asper A; Mittal A; Shome D; Parbhoo D; Thanzama J; Doshi K; Sachde N; Gaunkar R; Kapoor R; Thakkar R; Sion S; Shetty S; Kumar V; Parveen V; Singhal V
    J Cosmet Dermatol; 2022 Feb; 21(2):580-589. PubMed ID: 34997995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichoscopic Findings in Androgenetic Alopecia.
    Kasumagic-Halilovic E
    Med Arch; 2021 Apr; 75(2):109-111. PubMed ID: 34219869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
    Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
    Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet counts and activator in platelet-rich plasma on the treatment of androgenetic alopecia, split-head comparison: A randomised, double-blind study.
    Singh SK; Singh S
    Indian J Dermatol Venereol Leprol; 2023; 89(5):647-655. PubMed ID: 37067143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of platelet-rich plasma in androgenetic alopecia patients.
    Butt G; Hussain I; Ahmed FJ; Choudhery MS
    J Cosmet Dermatol; 2019 Aug; 18(4):996-1001. PubMed ID: 30393988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical observation of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male androgenetic alopecia.
    Liu C; Zhao H; Zhang Y; Wu W
    J Cosmet Dermatol; 2022 Sep; 21(9):4053-4059. PubMed ID: 35037386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment.
    Panchaprateep R; Lueangarun S
    Dermatol Ther (Heidelb); 2020 Dec; 10(6):1345-1357. PubMed ID: 32970299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of Trichoscopic Findings in Androgenetic Alopecia and the Disease Severity.
    Ummiti A; Priya PS; Chandravathi PL; Kumar CS
    Int J Trichology; 2019; 11(3):118-122. PubMed ID: 31360040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observing the clinical efficacy of combined serum microneedle therapy for moderate to severe androgenetic alopecia in scalp repair.
    Zhang F; Jia S; Ye B; Li F; Zhang J; Jin Q; Li M
    Skin Res Technol; 2024 Feb; 30(2):e13612. PubMed ID: 38348763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 5% minoxidil lotion monotherapy versus its combination with autologous platelet rich plasma in androgenetic alopecia in hundred males.
    Ray R; Sharma A
    Med J Armed Forces India; 2021 Jul; 77(3):355-362. PubMed ID: 34305291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.